TrialOral oncology2016

nab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma.

Douglas Adkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.